- Home
- RVMD vs G Comparison
RVMD vs G Comparison
Compare RVMD & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- G
- Stock Information
- Founded
- RVMD 2014
- G 1997
- Country
- RVMD United States
- G Bermuda
- Employees
- RVMD N/A
- G N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- G Professional Services
- Sector
- RVMD Health Care
- G Consumer Discretionary
- Exchange
- RVMD Nasdaq
- G Nasdaq
- Market Cap
- RVMD 7.5B
- G 7.4B
- IPO Year
- RVMD 2020
- G 2007
- Fundamental
- Price
- RVMD $38.11
- G $44.36
- Analyst Decision
- RVMD Strong Buy
- G Buy
- Analyst Count
- RVMD 12
- G 7
- Target Price
- RVMD $68.67
- G $48.00
- AVG Volume (30 Days)
- RVMD 3.3M
- G 1.7M
- Earning Date
- RVMD 08-06-2025
- G 08-07-2025
- Dividend Yield
- RVMD N/A
- G 1.53%
- EPS Growth
- RVMD N/A
- G N/A
- EPS
- RVMD N/A
- G 2.94
- Revenue
- RVMD N/A
- G $4,850,828,000.00
- Revenue This Year
- RVMD N/A
- G $5.77
- Revenue Next Year
- RVMD $241.39
- G $5.79
- P/E Ratio
- RVMD N/A
- G $15.07
- Revenue Growth
- RVMD N/A
- G 7.35
- 52 Week Low
- RVMD $29.17
- G $31.34
- 52 Week High
- RVMD $62.40
- G $56.76
- Technical
- Relative Strength Index (RSI)
- RVMD 47.77
- G 50.75
- Support Level
- RVMD $36.37
- G $41.59
- Resistance Level
- RVMD $38.97
- G $46.75
- Average True Range (ATR)
- RVMD 1.50
- G 0.89
- MACD
- RVMD 0.02
- G 0.27
- Stochastic Oscillator
- RVMD 40.07
- G 61.01
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.